Anna Nagel1, Agata Łaszewska1, Gerald Haidinger2, Judit Simon3. 1. Department of Health Economics, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria. 2. Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria. 3. Department of Health Economics, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria. judit.simon@meduniwien.ac.at.
Abstract
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) reached Austria in February 2020. This study aims to describe the first 8 weeks of the Austrian epidemic and reflect on the potential mental health consequences as known at that time. METHODS: Data on Austrian Coronavirus Disease 19 (COVID-19) epidemiological indicators and number of tests were obtained from official registers. Relative risks (RRs) of infection and death from COVID-19 were calculated for sex and age groups (< 65 years and ≥ 65 years). Public health measures introduced to reduce the spread of COVID-19 were identified via online media research. A rapid review of initial evidence on mental health consequences of the pandemic was performed in PubMed and medRxiv. RESULTS: By 21 April 2020 the case count in Austria was 14,810 after a peak of new daily infections mid-March. The RR of death for age ≥ 65 years was 80.07 (95% confidence interval, CI 52.64-121.80; p < 0.0001) compared to those aged < 65 years. In men the RR of death was 1.44 (95% CI 1.20-1.73; p < 0.0001) compared to women. Wide-ranging public health measures included avoidance of case importation, limitation of social contacts, hygiene measures, testing, case tracking, and the call for COVID-19-related research. International rates of psychiatric symptoms during the initial lockdowns exceeded typical levels: anxiety (6%-51%), depression (17%-48%) and posttraumatic stress (5%-54%). CONCLUSION: Data show great vulnerability of older people also in Austria. Severe mental health impacts can be expected with need for proper assessment of the long-term consequences of this pandemic.
BACKGROUND:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) reached Austria in February 2020. This study aims to describe the first 8 weeks of the Austrian epidemic and reflect on the potential mental health consequences as known at that time. METHODS: Data on Austrian Coronavirus Disease 19 (COVID-19) epidemiological indicators and number of tests were obtained from official registers. Relative risks (RRs) of infection and death from COVID-19 were calculated for sex and age groups (< 65 years and ≥ 65 years). Public health measures introduced to reduce the spread of COVID-19 were identified via online media research. A rapid review of initial evidence on mental health consequences of the pandemic was performed in PubMed and medRxiv. RESULTS: By 21 April 2020 the case count in Austria was 14,810 after a peak of new daily infections mid-March. The RR of death for age ≥ 65 years was 80.07 (95% confidence interval, CI 52.64-121.80; p < 0.0001) compared to those aged < 65 years. In men the RR of death was 1.44 (95% CI 1.20-1.73; p < 0.0001) compared to women. Wide-ranging public health measures included avoidance of case importation, limitation of social contacts, hygiene measures, testing, case tracking, and the call for COVID-19-related research. International rates of psychiatric symptoms during the initial lockdowns exceeded typical levels: anxiety (6%-51%), depression (17%-48%) and posttraumatic stress (5%-54%). CONCLUSION: Data show great vulnerability of older people also in Austria. Severe mental health impacts can be expected with need for proper assessment of the long-term consequences of this pandemic.
Entities:
Keywords:
Austria; COVID-19; Mental health; Public health measures; Relative risk
Authors: Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson Journal: Lancet Infect Dis Date: 2020-03-30 Impact factor: 25.071
Authors: Mohamed F Jalloh; Wenshu Li; Rebecca E Bunnell; Kathleen A Ethier; Ann O'Leary; Kathy M Hageman; Paul Sengeh; Mohammad B Jalloh; Oliver Morgan; Sara Hersey; Barbara J Marston; Foday Dafae; John T Redd Journal: BMJ Glob Health Date: 2018-03-17
Authors: Georg Beilhack; Rossella Monteforte; Florian Frommlet; Martina Gaggl; Robert Strassl; Andreas Vychytil Journal: Front Immunol Date: 2021-12-02 Impact factor: 7.561